GSK's gepotidacin shows potential in urinary tract infections
(Alliance News) - GSK PLC on Saturday announced positive phase three data that showed potential for its gepotidacin antibiotic to be the "first" in a new class of oral antibiotics for uncomplicated urinary tract infections in "over 20 years". Read More